Prospective randomised study of the effect of two levels of hemodilution during cardiopulmonary bypass on postoperative renal function
| ISRCTN | ISRCTN79851724 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN79851724 |
| Secondary identifying numbers | N0084118518 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 05/12/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Levent Guvendik
Scientific
Scientific
CardioThoracic Surgical Unit
Castle Hill Hospital
Castle Road
Cottingham
HU16 5JQ
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Scientific title | Prospective randomised study of the effect of two levels of hemodilution during cardiopulmonary bypass on postoperative renal function |
| Study objectives | To assess whether or not thinning the blood during surgery reduces the likelihood of kidney problems. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Cardiovascular: Cardiopulmonary bypass |
| Intervention | Hemodilution level 1 vs hemodilution level 2. Five blood and urine samples will be taken: after anaesthesia but before surgery, at the end of the operation, 12 h after, 1 day after and 2 days after. |
| Intervention type | Procedure/Surgery |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 06/12/2002 |
| Completion date | 01/01/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | 60 patients |
| Key inclusion criteria | Not provided at time of registration |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 06/12/2002 |
| Date of final enrolment | 01/01/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Castle Hill Hospital
Cottingham
HU16 5JQ
United Kingdom
HU16 5JQ
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.doh.gov.uk |
|---|
Funders
Funder type
Research organisation
The North and South Bank Research and Development Consortium (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
